MarginsXMarginsX
Home › Markets › Health Care › ISPC

iSpecimen Inc. (ISPC)

ISPC trades on Nasdaq in Health Care, Biotechnology: Commercial Physical & Biological Resarch. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6049
-8.17% on the day
Market cap
$3.3M
Nano cap
Revenue · 2025
$1.9M
-79.2% on 2024
Net income · 2025
-$10.5M
-543.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1558569/000121390026038607/0001213900-26-038607-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerISPC on Nasdaq
SectorHealth Care
IndustryBiotechnology: Commercial Physical & Biological Resarch
CountryUnited States
IPO year2021
SEC CIK0001558569
SEC industry codeServices-Commercial Physical & Biological Research
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.9M
Net income-$10.5M
Operating income-$9.0M
Net margin-543.7%
Operating margin-465.4%
Revenue growth-79.2%
Cash$6.9M
Total assets$9.5M
P/E (computed)Net income was not positive
P/S (computed)1.7×

Warning signs

Cash runway
7.6 months
$4.4M cash at June 30, 2026
Share count, 1 year
+1718.7%
2025-08-14 to 2026-08-14 · +22125.8% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued."
10-Q 2026-08-14
Cash and burn$4.4M cash; operating cash flow -$1.8M a quarter.Report 2026-06-30
Shares outstanding2,518,590 (2026-08-14); 5,539,345 a year earlier; 9,065,483 three years earlier. 1y figure adjusted for splits (1-for-40 overall); 3y figure adjusted for splits (1-for-800 overall).Cover page 2026-08-14
Reverse splits, 3 years2; latest 1-for-40 on 2026-04-28Source 2026-04-28
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-06-04
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-06-01
AuditorBush & Associates CPA LLC, Las Vegas, Nevada, United States; changed auditors 1 time in 24 months8-K 4.01 2025-03-11
Late filings, 12 months2 NT noticesNT 10-Q 2026-05-18
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 5,426,567 shares at the 2026-11-13 price; the latest SEC cover count is 2,518,590 as of 2026-08-14. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$152K-$1.4M-$690K$4.4MNo debt tags$466K10-Q 2026-08-14
Q1 2026
2026-03-31
$156K-$2.3M-$3.4M$2.8MNo debt tags$1.0M10-Q 2026-05-18
Q4 2025
2025-12-31
$52K-$5.0M-$917K$6.9MNo debt tags$1.9M10-K 2026-04-01
Q3 2025
2025-09-30
$107K-$2.8M-$2.0M$2.8MNo debt tags$3.4M10-Q 2025-11-17
Q2 2025
2025-06-30
$713K-$1.0M-$192K$589KNo debt tags$5.9M10-Q 2026-08-14
Q1 2025
2025-03-31
$1.1M-$1.7M-$1.1M$783KNo debt tags$8.1M10-Q 2026-05-18
Q4 2024
2024-12-31
$1.5M-$6.0M-$3.6M$1.9MNo debt tags$9.3M10-K 2026-04-01
Q3 2024
2024-09-30
$2.7M-$1.4M-$1.1M$1.8M$864K$10.4M10-Q 2025-11-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B42026-08-07
Latest annual report
ANNUAL REPORT
10-K2026-04-01
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-14
Latest current report
CURRENT REPORT
8-K2026-11-09
Latest proxy
PROXY STATEMENT
PRE 14A2026-10-30

Source: SEC EDGAR submissions feed, 334 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-19.0%
1 month-39.0%
3 months-71.3%
Year to date-93.7%
1 year-97.3%
From 52-week high-97.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Commercial Physical & Biological Resarch

TickerCompanyPriceDayMarket cap
BIAFbioAffinity Technologies Inc.$2.00-9.09%$3.6M
ONMDOneMedNet Corp$4.86-8.99%$29.2M
MXCTMaxCyte Inc.$1.18-0.84%$121.8M
NRCNRC Health$26.33-0.87%$558.8M
OABIOmniAb Inc.$4.89-0.41%$713.3M
ABSIAbsci Corporation$7.47-11.54%$1.3B
ICLRICON plc$191.40-1.67%$14.7B
CRLCharles River Laboratories International Inc.$335.52-0.72%$16.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier